Submitted by Anonymous (not verified) on 1 September 2023 - 11:13
Human medicines European public assessment report (EPAR): Revolade, eltrombopag, Purpura, Thrombocytopenic, Idiopathic, Date of authorisation: 11/03/2010, Revision: 34, Status: Authorised
Source: